Skip to content Skip to footer

GBM AGILE

GBM – One of the Most Deadly Cancers GBM continues to face limited treatment options and devastating survival rates. AFCR is committed to accelerating breakthrough solutions. The Urgent Need for Innovation 95%​ GBM kills 95% of patients within five years of diagnosis​ 240,000​ Each Year,…

Read More